Ali Artaman
- PhD, 2013, Michigan State University, East Lansing, Michigan, United States of America
- MS, 2006, Michigan State University, East Lansing, Michigan, United States of America
- MHA, 2003, University of Ottawa, Ottawa, Canada
- MD, 1994, Ferdowsi University, Mashhad, Iran
- Global Health Epidemiology
- Musculoskeletal Health
- Primary Care
- Assistant Professor (F/T), Zayed University, Dubai, United Arab Emirates, 2021-Present
- Assistant Professor (P/T), Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates, 2016-2021
- Assistant Professor (P/T), University of Manitoba, Winnipeg, Canada, 2016-2019
- Expert in Epidemiology [Consultant], World Health Organization, Regional Office for Europe, Kazakhstan, 2020
- Senior Epidemiologist/ Director, Epidemiology [F/T], Cancer Care Manitoba, Winnipeg, Canada, 2015-2020
- Research Scientist, Retrospective Observational Studies [F/T], Evidera, Inc., Lexington, United States of America, 2014
- Manager, Epidemiology, Surveillance and Research Department [F/T], Eastern Ontario Health Unit, Cornwall, Canada, 2012-2014
- Manager, Epidemiology Department [F/T], Windsor-Essex County Health Unit, Windsor, Canada, 2008-2012
- Research Associate/ Co-investigator [P/T], Department of Epidemiology, Michigan State University, East Lansing, United States of America, 2007-2010
- Study Coordinator [P/T], Data Coordinating Center for Autism and Other Developmental Disabilities, College of Human Medicine, Michigan State University, East Lansing, United States of America, 2004-2007
- Intern, International Health, Canadian Society for International Health, Ottawa, Canada, 1999
- Global Burden of Diseases, Injuries, Risk Factors (GBD) Study, Senior Collaborator, Institute for Health Metrics and Evaluation, University of Washington, United States of America, 2013-Present
- International Epidemiological Association, Lifetime Member, 2011-Present
- Artaman A, Bekele HT, Millar R. Strengthening global health education in the UAE: assessing the current landscape and future directions. Front Public Health. 2025 Jun 12;13:1584880. doi: 10.3389/fpubh.2025.1584880. PMID: 40575104; PMCID: PMC12198231.
- GBD 2019 Acute and Chronic Care Collaborators [incl. Artaman A]. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 7;16(1):4235. doi: 10.1038/s41467-025-56910-x. PMID: 40335470; PMCID: PMC12059133.
- GBD 2021 Gout Collaborators [incl. Artaman A]. Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024 Aug;6(8):e507-e517. doi: 10.1016/S2665-9913(24)00117-6. Epub 2024 Jul 9. Erratum in: Lancet Rheumatol. 2024 Nov;6(11):e749. doi: 10.1016/S2665-9913(24)00303-5. PMID: 38996590; PMCID: PMC11263476.
- GBD 2019 MSK in Adolescents Collaborators [incl. Artaman A]. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050. Med. 2024 Aug 9;5(8):943-962.e6. doi: 10.1016/j.medj.2024.04.009. Epub 2024 Jun 3. PMID: 38834074; PMCID: PMC11321819.
- GBD 2019 Asia and All Cancers Collaborators [incl. Artaman A]. Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Reg Health Southeast Asia. 2024 Jan 2;21:100333. doi: 10.1016/j.lansea.2023.100333. PMID: 38361599; PMCID: PMC10866992.
- Hassen N, Lacaille D, Xu A, GBD RA Collaborator Group [incl. Artaman A]. National burden of rheumatoid arthritis in Canada, 1990-2019: findings from the Global Burden of Disease Study 2019 - a GBD collaborator-led study. RMD Open. 2024 Jan 12;10(1):e003533. doi: 10.1136/rmdopen-2023-003533. PMID: 38216285; PMCID: PMC10806499.
- Saengow U, Chaiyasong S, Nontarak J, Saokaew S, Artaman A, Vichitkunakorn P, Waleewong O. Estimated cost of extra work hours from co-workers' drinking in Thailand. Drug Alcohol Rev. 2024 Jan;43(1):188-198. doi: 10.1111/dar.13768. Epub 2023 Oct 25. PMID: 37881158.
- GBD 2019 Cancer Risk Factors Collaborators [incl. Artaman A]. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. Lancet. 2022 Aug 20;400(10352):563-591. doi: 10.1016/S0140-6736(22)01438-6.
- Global Burden of Disease 2019 Cancer Collaboration [incl. Artaman A]. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
- Burstein R, Henry NJ, Collison ML, et al. [incl. Artaman A]. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nat Med. 2021 Oct;27(10):1761-1782. doi: 10.1038/s41591-021-01498-0.
- United Arab Emirates University-Zayed University Joint Research, Grant, 2025-2027
- Zayed University Research Incentive Fund, Grant, 2024-2026
- Zayed University Institute for Social and Economic Research Policy Impact Program, Grant, 2024-2025
- Zayed University Start-Up, Grant, 2023-2024